Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lemberger

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Clinical Chemistry|October 1, 1982
Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detectionJ F Nash, R J Bopp, R H Carmichael, et al.
Journal of Clinical Pharmacology|May 1, 1985
Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjectsN A Farid, R F Bergstrom, E A Ziege, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1985
Clinical pharmacology of tomoxetine, a potential antidepressantR L Zerbe, H Rowe, G G Enas, et al.
Clinical Pharmacology and Therapeutics|September 1, 1972
Cardiovascular effects of delta-9-tetrahydrocannabinol in manJ L Weiss, A M Watanabe, L Lemberger, et al.
Clinical Pharmacology and Therapeutics|April 1, 1978
Fluoxetine, a selective serotonin uptake inhibitorL Lemberger, H Rowe, R Carmichael, et al.
Science (New York, N.Y.)|May 26, 1972
Effects on humans of 9 -tetrahydrocannabinol administered by smokingM Galanter, R J Wyatt, L Lemberger, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1970
Effect of medroxyprogesterone acetate (Provera) on the metabolism and biological activity of testosteroneG G Gordon, A L Southren, S Tochimoto, et al.
Clinical Pharmacology and Therapeutics|July 1, 1977
Physiologic disposition of nabilone, a cannabinol derivative, in manA Rubin, L Lemberger, P Warrick, et al.
Toxicology and Applied Pharmacology|March 15, 1984
Pharmacological activity of the basic fraction of marihuana whole smoke condensate alone and in combination with delta-9-tetrahydrocannabinol in miceJ M Johnson, L Lemberger, M Novotny, et al.
Clinical Pharmacology and Therapeutics|November 1, 1975
Panel 1: phase I investigationsL I Goldberg, G H Besselaar, J D Arnold, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Clinical Chemistry|October 1, 1982
Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detectionJ F Nash, R J Bopp, R H Carmichael, et al.
Journal of Clinical Pharmacology|May 1, 1985
Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjectsN A Farid, R F Bergstrom, E A Ziege, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1985
Clinical pharmacology of tomoxetine, a potential antidepressantR L Zerbe, H Rowe, G G Enas, et al.
Clinical Pharmacology and Therapeutics|September 1, 1972
Cardiovascular effects of delta-9-tetrahydrocannabinol in manJ L Weiss, A M Watanabe, L Lemberger, et al.
Clinical Pharmacology and Therapeutics|April 1, 1978
Fluoxetine, a selective serotonin uptake inhibitorL Lemberger, H Rowe, R Carmichael, et al.
Science (New York, N.Y.)|May 26, 1972
Effects on humans of 9 -tetrahydrocannabinol administered by smokingM Galanter, R J Wyatt, L Lemberger, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1970
Effect of medroxyprogesterone acetate (Provera) on the metabolism and biological activity of testosteroneG G Gordon, A L Southren, S Tochimoto, et al.
Clinical Pharmacology and Therapeutics|July 1, 1977
Physiologic disposition of nabilone, a cannabinol derivative, in manA Rubin, L Lemberger, P Warrick, et al.
Toxicology and Applied Pharmacology|March 15, 1984
Pharmacological activity of the basic fraction of marihuana whole smoke condensate alone and in combination with delta-9-tetrahydrocannabinol in miceJ M Johnson, L Lemberger, M Novotny, et al.
Clinical Pharmacology and Therapeutics|November 1, 1975
Panel 1: phase I investigationsL I Goldberg, G H Besselaar, J D Arnold, et al.
Pageof 8